Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Cervical Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
39 drugs · 148 active trials
4 drugs · 53 active trials
Outside the funnel: Phase not stated 1. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 10 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Pembrolizumab | Approved | Phase 3 | 27 | 15 | 5 | 47 | 3 | US | Sep 4, 2014 | Dec 18, 2015 |
| Bevacizumab | Approved | Phase 3 | 20 | 11 | 15 | 61 | 1 | US | Feb 26, 2004 | 2002-04 |
| Topotecan | Approved | Phase 3 | 4 | 1 | 9 | 27 | 2 | EU, US | May 28, 1996 | 1996-12 |
| Tisotumab Vedotin | Approved | Phase 4 | 2 | 1 | 2 | 5 | 2 | EU, US | Sep 20, 2021 | Jun 12, 2018 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.